Bedaquiline-Pretomanid-Linezolid Regimens for Drug-Resistant Tuberculosis

Conradie, F; Bagdasaryan, TR; Borisov, S; Howell, P; Mikiashvili, L; Ngubane, N; Samoilova, A; Skornykova, S; Tudor, E; Variava, E; Yablonskiy, P; Everitt, D; Wills, GH; Sun, EGE; Olugbosi, M; Egizi, E; Li, MC; Holsta, A; Timm, J; Bateson, A; Crook, AM; Fabiane, SM; Hunt, R; McHugh, TD; Tweed, CD; Foraida, S; Mendel, CM; Spigelman, M

Tweed, CD (通讯作者)，UCL, Inst Clin Trials & Methodol, Med Res Council Clin Trials Unit, 90 High Holborn,2nd Fl, London WC1V 6LJ, England.

NEW ENGLAND JOURNAL OF MEDICINE, 2022; 387 (9): 810

Abstract

BACKGROUND The bedaquiline-pretomanid-linezolid regimen has been reported to have 90% efficacy against highly drug-resistant tuberculosis, but the inc......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索